We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma (STAR CNS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05242146
Recruitment Status : Active, not recruiting
First Posted : February 16, 2022
Last Update Posted : April 20, 2023
Information provided by (Responsible Party):
Gossamer Bio Inc. ( GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 2024
Estimated Study Completion Date : October 2024